Yuan-zhong Yang

State Key Laboratory Of Oncology In South China, No. 651, Dongfeng Road East
Guangzhou, 510060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Evolution of HER2-low expression from primary to paired metastatic gastric cancer lesions.

Evolution of HER2-low expression from primary to paired metastatic gastric cancer lesions.

Journal: NPJ precision oncology

Published: November 04, 2024

Primary adenocarcinoma of the spermatic cord: a case report and review of the literature.

Primary adenocarcinoma of the spermatic cord: a case report and review of the literature.

Journal: Diagnostic pathology

Published: May 10, 2024

Nomogram for predicting the biochemical recurrence of prostate cancer after neoadjuvant androgen deprivation therapy.

Nomogram for predicting the biochemical recurrence of prostate cancer after neoadjuvant androgen deprivation therapy.

Journal: International urology and nephrology

Published: April 05, 2023

Combined low levels of H4K16ac and H4K20me3 predicts poor prognosis in breast cancer.

Combined low levels of H4K16ac and H4K20me3 predicts poor prognosis in breast cancer.

Journal: International journal of clinical oncology

Published: April 01, 2023

Survival is associated with repressive histone trimethylation markers in both HR-positive HER2-negative and triple-negative breast cancer patients.

Survival is associated with repressive histone trimethylation markers in both HR-positive HER2-negative and triple-negative breast cancer patients.

Journal: Virchows Archiv : an international journal of pathology

Published: December 29, 2022

Association of Enolase-1 with Prognosis and Immune Infiltration in Breast Cancer by Clinical Stage.

Association of Enolase-1 with Prognosis and Immune Infiltration in Breast Cancer by Clinical Stage.

Journal: Journal of inflammation research

Published: November 05, 2022

AGR2 and FOXA1 as prognostic markers in ER-positive breast cancer.

AGR2 and FOXA1 as prognostic markers in ER-positive breast cancer.

Journal: BMC cancer

Published: July 08, 2022

Association of H3K9me3 with breast cancer prognosis by estrogen receptor status.

Association of H3K9me3 with breast cancer prognosis by estrogen receptor status.

Journal: Clinical epigenetics

Published: March 24, 2022

Prognostic value of glutaminase 1 in breast cancer depends on H3K27me3 expression and menopausal status.

Prognostic value of glutaminase 1 in breast cancer depends on H3K27me3 expression and menopausal status.

Journal: Virchows Archiv : an international journal of pathology

Published: July 20, 2021

Association between somatic RET mutations and clinical and genetic characteristics in patients with metastatic colorectal cancer.

Association between somatic RET mutations and clinical and genetic characteristics in patients with metastatic colorectal cancer.

Journal: Cancer medicine

Published: May 13, 2021

Time-varying effects of FOXA1 on breast cancer prognosis.

Time-varying effects of FOXA1 on breast cancer prognosis.

Journal: Breast cancer research and treatment

Published: November 23, 2020

SSTR2 is a prognostic factor and a promising therapeutic target in glioma.

SSTR2 is a prognostic factor and a promising therapeutic target in glioma.

Journal: American journal of translational research

Published: October 31, 2020

Showing 1-12 of 27

Last Updated: 09/26/2026